hsTnT in Patients Admitted to the ED With Atrial Fibrillation in the Era of NOACs - Heidelberg Registry of Atrial Fibrillation

High-Sensitivity Cardiac Troponin T in Patients Admitted to the Emergency Department With Atrial Fibrillation in the Era of Novel Oral Anticoagulants - Heidelberg Registry of Atrial Fibrillation

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT03344237

Acronym

HERA-FIB

Enrollment

5000

Registered

2017-11-17

Start date

2017-09-14

Completion date

2020-03-31

Last updated

2019-09-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atrial Fibrillation

Brief summary

The purpose of the Heidelberg Registry of Atrial Fibrillation (HERA-FIB) is to collect data on the prevalence and clinical significance of elevated cardiac troponin in a large registry of unselected patients with atrial fibrillation presenting to an emergency department in the era of novel oral anticoagulants (NOACs).

Interventions

None listed

Study design

Observational model

OTHER

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Inclusion criteria

* documented atrial fibrillation * availability of at least one hsTnT measurement

Exclusion criteria

* none

Design outcomes

Primary

Measure	Time frame
Nonfatal myocardial infarction	Follow up after at least 6 months
Vascular and non-vascular death	Follow up after at least 6 months
Stroke/systemic embolism	Follow up after at least 6 months

Secondary

Measure	Time frame
Stroke, systemic embolism, myocardial infarction, vascular death, non-vascular death, composite endpoint of vascular and non-vascular death, nonfatal MI, stroke/systemic embolism	Follow up after at least 6 months

Other

Measure	Time frame
Major bleeding by definition of International Society on Thrombosis and Haemostasis (ISTH)	Follow up after at least 6 months

Countries

Germany

Contacts

Primary ContactMehrshad Vafaie, Dr.med.Dr.med.univ.

mehrshad.vafaie@med.uni-heidelberg.de00496221/56-8676

Outcome results